Companies: 48,687 Total Market Cap: 127305801127228.72

Danaher

NYSE: DHR
Healthcare Diagnostics & Research
Rank #108
Market Cap 142.45 B
Volume 3.16 M
Price 199.05
Change (%) 1.19%
Country or region United States United States

Danaher's latest marketcap:

142.45 B

As of May 3, 2025, Danaher's market capitalization has reached $142.45 B. According to our data, Danaher is the 108th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 142.45 B
Revenue (ttm) 23.82 B
Net Income (ttm) 3.77 B
Shares Out 715.67 M
EPS (ttm) 5.16
Forward PE 25.36
Ex-Dividend Date March 28, 2025
Earnings Date April 22, 2025
Market Cap Chart
Data Updated: May 3, 2025

Danaher's yearly market capitalization.

Danaher has seen its market value grow from $7.33 B to $141.09 B since 1998, representing a total increase of 1,824.53% and an annual compound growth rate (CAGR) of 11.89%.
Date Market Cap Change (%)
April 25, 2025 $141.09 B -14.9%
December 31, 2024 $165.80 B -3.01%
December 29, 2023 $170.94 B -11.53%
December 30, 2022 $193.22 B -17.82%
December 31, 2021 $235.10 B 48.98%
December 31, 2020 $157.80 B 43.14%
December 31, 2019 $110.24 B 52.53%
December 31, 2018 $72.28 B 11.94%
December 29, 2017 $64.57 B 19.92%
December 30, 2016 $53.84 B -15.41%
December 31, 2015 $63.65 B 5.68%
December 31, 2014 $60.23 B 11.9%
December 31, 2013 $53.82 B 39%
December 31, 2012 $38.72 B 19.93%
December 30, 2011 $32.29 B 4.66%
December 31, 2010 $30.85 B 27.69%
December 31, 2009 $24.16 B 33.51%
December 31, 2008 $18.09 B -33.56%
December 31, 2007 $27.23 B 22.14%
December 29, 2006 $22.30 B 29.74%
December 30, 2005 $17.19 B -3%
December 31, 2004 $17.72 B 25.76%
December 31, 2003 $14.09 B 40.7%
December 31, 2002 $10.01 B 16.16%
December 31, 2001 $8.62 B -11.14%
December 29, 2000 $9.70 B 41.23%
December 31, 1999 $6.87 B -6.31%
December 31, 1998 $7.33 B

Company Profile

About Danaher Corporation

Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services globally, with a strong presence in the United States and China. The company operates through three key segments:

Business Segments

  • Biotechnology Segment: Provides bioprocessing technologies, consumables, and services for therapeutic development and manufacturing. This includes cell culture media, chromatography resins, filtration solutions, lab-scale protein purification tools, and diagnostic assay development reagents.
  • Life Sciences Segment: Offers advanced instruments and solutions such as mass spectrometers, flow cytometry systems, genomics tools, microscopes, and protein consumables. Brands under this segment include ABCAM, BECKMAN COULTER, IDT, LEICA MICROSYSTEMS, and SCIEX.
  • Diagnostics Segment: Delivers clinical instruments, consumables, and software for hospitals, labs, and critical care settings. Products cover clinical chemistry, immunoassay, hematology, and microbiology.

Company Background

Originally founded in 1969 as Diversified Mortgage Investors, Inc., the company rebranded as Danaher Corporation in 1984. Today, it is headquartered in Washington, D.C., and continues to drive innovation across biotechnology, life sciences, and diagnostics.

Frequently Asked Questions

As of May 3, 2025, Danaher (including the parent company, if applicable) has an estimated market capitalization of $142.45 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.

Danaher global market capitalization ranking is approximately 108 as of May 3, 2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

Stock Detail

Country or region United States
Founded 1969
IPO Date n/a
Employees 63,000
CEO Rainer Blair
Sector Healthcare
Industry Diagnostics & Research
Address 2200 Pennsylvania Avenue N.W., Suite 800W
Washington, District of Columbia 20037-1701
United States
People Also Watch
TMO
423.55 1.19%
SWX-LONN
725.16 1.19%
IDXX
471.75 1.19%
A
108.63 1.19%